v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current Assets:    
Cash and Cash Equivalents $ 10,955,359 $ 8,696,570
Short-Term Investments 2,916,701 8,392,513
Prepaid Expenses and Other Current Assets 1,206,339 1,141,804
Collaboration Receivables 1,544,253 1,522,770
Tax and Other Receivables 1,906,923 1,793,459
Prepaid Collaboration Expenses 153,273 201,332
Total Current Assets 18,682,848 21,748,448
Non-Current Assets:    
Property and Equipment, Net 86,815 91,672
Restricted Cash 4,687 4,566
Intangible Assets and In-Process R&D, Net 2,063,100 2,063,100
Operating Lease Right-of-Use Assets 301,486 285,827
Other Assets 88,153 59,687
Total Assets 21,227,089 24,253,300
Current Liabilities:    
Accounts Payable 594,874 1,060,306
Accrued Expenses 2,025,173 2,406,731
Operating Lease Liabilities 178,217 164,461
Total Current Liabilities 2,798,264 3,631,498
Non-Current Liabilities:    
Contingent Consideration 2,946,743 2,939,316
Deferred Tax Liability 102,152 102,152
Deferred Collaboration Revenue 1,250,000 1,250,000
Non-Current Operating Lease Liabilities 195,369 203,798
Total Non-Current Liabilities 4,494,264 4,495,266
Total Liabilities 7,292,528 8,126,764
Commitments and Contingencies (Note 9)
Stockholders’ Equity:    
Preferred Stock, $0.01 Par Value: 10,000,000 shares authorized; 3,750 designated Series A, 0 shares issued and outstanding; 10,000 designated Series B, 0 shares issued and outstanding; 10,000 shares designated Series C, 0 shares issued and outstanding; 20,000 shares designated Series D, 7 shares issued and outstanding; 1,280 shares designated Series E, 0 shares issued and outstanding; 3,908 shares designated Series F, 420 issued and outstanding at March 31, 2026 and December 31, 2025, respectively 4 4
Common Stock, $0.01 Par Value: 150,000,000 shares authorized; 3,993,469 and 3,761,739 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 277,606 275,289
Additional Paid-In Capital 170,521,007 170,314,656
Accumulated Deficit (156,635,260) (154,217,276)
Accumulated Other Comprehensive Loss (228,796) (246,137)
Total Stockholders’ Equity 13,934,561 16,126,536
Total Liabilities and Stockholders’ Equity $ 21,227,089 $ 24,253,300

Source

10-Q PDF XBRL Zip